Category: Lab Top-10
Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research
Bruker launches novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF fleX using AmberGen’s HiPLEX-IHC peptide code antibody probes, combined with unbiased lipidomics, glycomics and metabolomics tissue imaging New Canopy CellScape™ single cell, highly quantitative spatial proteomic ChipCytometry™ platform features fully automated iterative staining using open-source antibodies for virtually unlimited immuno-oncology marker analysis on whole tissue... Read more
Thermo Fisher Scientific to Host Investor Day
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2022 Investor Day on Wednesday, May 18, starting at 9:00 a.m. (ET), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City. The format will feature presentations by... Read more
PerkinElmer Showcases Expanded Technology and Solutions Portfolio to Accelerate Cancer Research at AACR Annual Meeting
Innovative solutions offer researchers flexible therapeutic tools to deepen understanding of cancer’s biology to enable advances in immunotherapy, targeted treatments, and personalized medicine WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, will be at The American Association for Cancer Research (AACR) Annual Meeting from April 8-13 in New Orleans (booths... Read more
PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System
Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 7, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega® imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated... Read more
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 28, 2022
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2022 before the market opens on Thursday, April 28, 2022, and will hold a conference call on the same day at 8:30 a.m. EST. During the call, the... Read more
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology (PAT), pharma manufacturing automation and Quality Assurance (QA) software and systems integration, based in the United Kingdom. The Optimal biopharma tools acquisition strengthens Bruker as a key software and... Read more
PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 4, 2022– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced two ready-to-use HTRF® and AlphaLISA® no-wash assay kits designed to quickly and easily detect and quantify CHO HCP impurities during... Read more
Bruker Expands dia-PASEF® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR
Innovative TIMScore™ algorithm, combined with TIMS DIA- NN deep learning, now integrated into ‘Run & Done’ Bruker PaSER™2022 proteomics system Identifies and quantifies more than 8000 protein groups (PG) in 35 minute-gradient single dia-PASEF runs from ultra-deep libraries containing over 13,000 PGs in cell-line assays with 1% FDR (false discovery rate) specificity Over 25% more... Read more